Semarion

Semarion builds advanced materials platforms to transform cell‑based assays and speed up in vitro drug discovery. Their proprietary SemaCyte® microcarriers are ultra‑miniaturised, magnetically steerable mobile wells that support adherent cell colonies and can be frozen for assay‑ready use. By enabling seamless integration with existing workflows such as high‑throughput screening and imaging, these microcarriers boost flexibility, throughput and experimental depth. Born from cross‑disciplinary expertise spanning microfabrication and cell biology, Semarion’s platform addresses long‑standing bottlenecks in drug screening by offering scalable, reproducible and automation‑friendly solutions. With a mission to deliver better data faster, Semarion empowers researchers to focus on scientific discovery and accelerate the development of new medicines.